3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Cortexyme Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Study of COR588 COR588, Placebo - Healthy Volunteers | Phase 1 | Completed | Cortexyme Inc. | 64 | 2021-08-26 | 2022-07-20 |
| A Multiple Ascending Dose Study of COR388 COR388, Placebo - Alzheimer Disease | Phase 1 | Completed | Cortexyme Inc. | 33 | 2018-03-06 | 2018-11-07 |
| Study of COR388 HCl in Healthy Subjects COR388, Placebo - Healthy Subjects | Phase 1 | Completed | Cortexyme Inc. | 34 | 2017-12-11 | 2018-04-18 |
COR388 (2)
United States (2) · Australia (1)